US stocks ended a volatile, holiday-shortened week mixed but resilient, as investors juggled Iran-war headlines, oil shock, and shifting Fed-cut expectations while the major indexes largely shook off early Thursday losses tied to Strait of Hormuz risks.
Index performance and tone
The…
Big Pharma spent the week shopping again, snapping up a fresh crop of biotech and pharmaceutical names in deals that underscore one message: pipelines are the new gold, and the majors are still happily paying spot prices. From autoimmune bets to allergy…
The stock market extended its relief rally on Wednesday, April 1, 2026, as Wall Street bet that war drums might finally be turning into negotiation notes, sending major indexes higher for a second straight day while oil lost some of its recent…
Wall Street closed the quarter on an upswing Tuesday, with bulls finally getting the last word in a month dominated by war headlines, oil shocks, and rate‑cut angst. Major indexes logged their biggest single‑day gains in roughly 10 months as investors bet…
Wall Street kicked off the final trading days of March with a split decision on Monday, as the Dow inched higher while the S&P 500 and Nasdaq slipped under the weight of faltering chip stocks and surging oil prices above 100 dollars…
Wall Street kicked off the final trading days of March with a split decision on Monday, as the Dow inched higher while the S&P 500 and Nasdaq slipped under the weight of faltering chip stocks and surging oil prices above 100 dollars…
Stocks limped into the close after dropping sharply throughout Thursday's session as oil prices spiked and Big Tech finally remembered stocks can, in fact, go down, with Wall Street nervously watching the Strait of Hormuz and its own valuation multiples at the…
U.S. stocks extended their relief rally on Wednesday, as Wall Street decided that a 15-point peace plan beats a $115 oil quote almost every time.
Indexes Rebound as War Premium Bleeds Out
Major indexes climbed after reports that Washington had sent Tehran…
GeoVax’s (GOVX) latest update on its GEO-MVA program reads less like a small-cap press release and more like a biotech coming-of-age story, with Phase 3 now on the horizon and global health agencies finally circling the dance floor. For investors, the mpox/smallpox…
Wall Street gave back part of Monday’s euphoric bounce on Tuesday as oil roared back above $92 and Middle East headlines reminded investors that risk never really takes a day off.
Indices: Rally Hangover, Not a Meltdown
US stocks slipped, but the…
